Anika Therapeutics Inc. (ANIK)

: ANIK · Real-Time Price · USD

n/a

n/a (n/a)

At close: Invalid Date

22.21

+1.97%

After-hours: 7:58 PM

The price, the headline numbers and the latest news, in one place.

No data available

Bid	n/a
Market Cap	n/a
Revenue (ttm)	120.65M
Net Income (ttm)	-3.12M
	0.19
	n/a
	n/a
	22.93
P/B (ttm)	2.12
P/S (ttm)	2.42
Earnings Date	Nov 2, 2023

Ask	n/a
Volume	NaN
Avg. Volume (20D)	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a - n/a
52-Week Range	n/a - n/a
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About ANIK

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; ...

Sector Healthcare

IPO Date May 3, 1993

Employees 235

Stock Exchange NasdaqGS

Ticker Symbol ANIK

Website https://www.anika.com

Full Company Profile

Financial Performance

In 2025, Anika Therapeutics's revenue was 112.82M, a decrease of -5.91% compared to the previous year's 119.91M. Earnings were -10.88M, a decrease of -80.7%.

Financial Statements